Aaron Levitt

Aaron Levitt

InvestorPlace Contributor

Aaron Levitt is an independent investment analyst and author living in State College, Pennsylvania. His work appears in several high profile publications in both print and on the web.

As an advocate for long-term globally oriented investing, Aaron believes that exchange traded funds have leveled playing field for Main Street. Following global macro-economic trends, investors now have several avenues to create great long term portfolios.

Aaron is a graduate of The Pennsylvania State University where he studied Economics and International Business. Aside for helping regular investors develop winning portfolios, his current projects include writing his first book on alternative energy investing.

Follow his picks and pans on Twitter at @AaronLevitt.

Recent Articles

Should Warren Buffett — And You — Buy More TEVA Stock Right Now?

By Aaron Levitt, InvestorPlace Contributor

Teva's turnaround is working, but a serious worry is now hitting shares. Should you be buying more TEVA stock with this looming danger?

3 Utility Stocks to Power Up Your Portfolio

By Aaron Levitt, InvestorPlace Contributor

A flight to safer equities is boosting the fortunes of utility stocks. Here are 3 utility stocks to make the most of the trend.

Build a Better Portfolio in 2019 With These 5 Core ETFs to Buy

By Aaron Levitt, InvestorPlace Contributor

These five ETFs to buy will help you build a better core portfolio and get better returns in the long run. Here's what investors need to know.

3 Best ETFs to Play Political Gridlock

By Aaron Levitt, InvestorPlace Contributor

With a split congress, you can't expect many new policies in the next two years. Here are three of the best ETFs to benefit from gridlock.

The New Amazon Blockchain Products Could Be Huge for AMZN

By Aaron Levitt, InvestorPlace Contributor

Amazon and Blockchain are a match made in heaven. It's latest moves into the space could be a huge revenue driver over the long haul.

5 Biotech Stocks to Scoop Up for Big Dividends

By Aaron Levitt, InvestorPlace Contributor

Biotech stocks can still pay you some big yields. Here are five of the best dividend stocks in the pharma sector.

3 Retail Stocks That Will Have a Blue Christmas

By Aaron Levitt, InvestorPlace Contributor

Some retail stocks continue to die a quick death. Odds are, these three won't be around too much longer.

Amazon Stock Is Unstoppable With Alexa Ad Revenue Revving Up

By Aaron Levitt, InvestorPlace Contributor

AMZN is starting to make money with Alexa and that's going to huge for Amazon stock. Here's what investors need to know.

With Improving Crude Oil Prices and Better Shale Returns, Big Oil Is Back!

By Aaron Levitt, InvestorPlace Contributor

After falling behind smaller rivals, a great quarter at Exxon and Chevron means only one thing. Big oil is back with a vengeance!

Forget the FANGs — Buy These 5 Tech Stocks Instead

By Aaron Levitt, InvestorPlace Contributor

There are better tech stocks than the FANGs right now. Here are five fast-growing picks that will have you forgetting about them.

Load More